The "host ceil infiltrates" in five patients with low-grade follicular lymphoma who had spontaneous regression without therapy were studied with the use of immunohistochemical methods applied to frozen sections. These infiltrates were compared with the "host cell infiltrates" in six patients with follicular lymphoma with progressive disease. The group with progressive disease was selected to be similar to the group with spontaneous regression in age, sex, histologic characteristics, and stage of disease. The patients with spontaneous regression had significantly more T-helper cells in the host cell infiltrate than the control patients. There were no statistically significant differences between the two groups in numbers of cytotoxic/suppressor T-cells, macrophages, Tac FOLLICULAR SMALL CLEAVED CELL lymphomas and follicular mixed small cleaved and large cell lymphomas are two of the three major categories of lowgrade lymphomas in the International Working Formulation. The patients with follicular lymphoma have relatively long median survivals and selected patients may be initially managed without therapy. In a recent study, spontaneous regressions (SRs) without therapy occurred in 19 of 83 patients with initially untreated low-grade lymphoma, including 30% of patients with follicular small cleaved cell lymphoma. 12 However, no distinctive clinical or histologic features were associated with regression in this retrospective study. 12 Immunologic studies of follicular lymphomas have shown that the tumor cells have a B-lineage phenotype and usually express immunoglobulins. 7 ' 0 ' 20 However, follicular lymphomas also contain a significant number of host cells, especially in interfollicular areas, mainly consisting of T-cells and macrophages. these patients, using the monoclonal antibody Ki-67. These results were compared with those obtained in follicular lymphomas from a matched group of patients with progressive disease.
Materials and Methods
Frozen tissue from five patients with follicular lymphoma who had SR without therapy was available for study in the Laboratory of Immunodiagnosis at Stanford University Medical Center. Frozen tissue from six patients with follicular lymphoma with progressive disease matched for age, sex, histologic characteristics, and stage of disease to the SR group was also available for study. The histologic diagnosis in all cases was confirmed by use of criteria recommended by the International Working Formulatioil (National Cancer Institute study). 18 The clinical features of the patients are summarized in Table 1 .
Immunoperoxidase staining was performed on cryostat sections prepared from fresh-frozen tissue. The staining consisted of a first-stage incubation with one of the following monoclonal antibodies: Ki-67 (courtesy H. Stein, West Berlin); anti-Leu-4 (CD3); anti-Leu-2 (CD8); anti-Leu-3a (CD4); anti-Tac (CD25, courtesy T. Waldmann, National Institute of Health); anti-interleukin-2 receptor (CD25, Becton-Dickinson, Mountain View, CA); anti-Leu-M3(CD14); anti-Leu-M5 (CD11C); Y182 (courtesy D. Y. Mason, Oxford); antiLeu-7; and anti-HLA-DR (la, courtesy R. Levy, Stanford). After washing, biotin-conjugated horse antimouse antibody (Vector Laboratories, Burlington, CA) was applied before a third stage of avidin-conjugated horseradish peroxidase (Vector). The sections were then incubated sequentially in diaminobenzldene, copper sulfate, and methylene blue counterstain. Duration of Regression (months) 14,9,NRtl2,NRt
• FSC = low-grade, follicular small cleaved cell lymphoma. $ NR = no recurrence at time of last follow-up at 54 and 65 months in two patients, whereas t FM •= low-grade, follicular mixed small cleaved and large cell lymphoma. disease recurred at 9, 12, and 14 months in other three patients.
age of the total cell population that stained for a given antibody was estimated, using 11 categories ranging from less than 1% to greater than or equal to 86%. 8 These estimates were made independently by three of the authors, who had no knowledge of clinical information. The mean percentages of the categories chosen by each of the three observers was then averaged for each antibody.
To confirm preliminary differences based on the estimation method, the percentage of cells expressing Leu-2, Leu-3, and Leu-4 in interfollicular areas was also determined by use of a counting method with a grid, as previously described. Estimates of the "host infiltrate" cells staining with each antibody are summarized in Table 2 . The estimates of the three observers were similar and rarely varied by more than 10% from each other. Similar estimates were obtained by the use of multiple antibodies to the same cell populations (macrophages, "natural killer" cells, and cells expressing the T-cell growth factor receptor).
Actual counts of the "host infiltrate" cells staining with anti-Leu-2, anti-Leu-3, and anti-Leu-4 are summarized in Table 3 . These results were similar to those obtained with the estimation method ( Table 2 The percentages of the "host infiltrate" cells in the patients with SR and in the control patients are summarized in Table 4 . The patients with SR had significantly more T-cells than the control patients. The increased number of T-cells in the patients with SR resulted from the significantly increased number of helper T-cells, as measured by expression of Leu-3 (see Figs. \A and B) . In contrast, the number of cytotoxic/suppressor T-cells, as measured by staining with anti-Leu-2, was the same in both groups. There were no statistically significant differences between the two groups in numbers of macrophages (staining with anti-Leu-M3), natural killer cells (staining with anti-Leu-7), or cells expressing the T-cell growth factor receptor (staining with Tac). Although the number of proliferating cells (Ki-67 positive) in the follicles of the regressing patients was less than the number in the follicles of the control group (27 vs. 34), the differences were not statistically significant (Figs. \C and D).
Discussion
Follicular lymphoma represents one of the most common types of human lymphoma. 12 In the past, there was doubt regarding the nature of these lesions, which led to the use of noncommittal terms such as "giant follicle hyperplasia" and "Brill-Symmers disease." 15 This doubt was based upon the morphologic similarity of lymphomatous follicles with normal follicles. Furthermore, when left untreated, some patients with follicular lymphoma exhibit waxing and waning of disease. 12 Recent studies using probes to antigen receptor molecules and genes have given new insights into this problem. Follicular lymphomas have been shown to be monoclonal B-cell neoplasms with a particular t(14;18) chromosomal translocation that results in the juxtaposition of the candidate proto-oncogene bcl-2 on chromosome 18 with the immunoglobulin heavy chain locus on chromosome 14.1.3-5,7,9-11,16,17,19-21 j n a pr j or studv ^y Horning and Rosenberg, 19 of 83 patients with untreated low-grade lymphoma had SR. 12 We had frozen lymphoma tissue from a few of these patients before their SR that provided us with the opportunity to study the cellular infiltrates with immunologic markers and to compare these infiltrates with those in a control group of patients without regression.
We found that the biopsies from patients with SR contained significantly more T-cells of the helper/inducer subtype. A predominance of helper/inducer Tcells has been observed in prior studies of patients with follicular lymphoma, and their presence in relatively increased numbers in biopsies from patients with SR suggests an active role for these cells in tumor contro 1.4,7,9,11,17 R ec ent studies of "host cell infiltrates" in patients having treatment with antiidiotype antibodies showed that the patients with the best clinical responses also had the most T-cells of the helper/inducer subset in their pretreatment biopsies. 614 In addition, we have recently observed that the number of helper/inducer Tcells in diffuse, small cell lymphoma biopsies from patients left untreated or treated by conventional methods correlates with survival (unpublished observations). These findings raise the possibility that class II major histocompatibility complex restricted Leu-3(CD4) + killer cells play a critical role in the control of low-grade follicular lymphomas. 13 The lack of expression of class II antigens by lymphoma cells in two progressing patients may be relevant if this hypothesis is correct. An alternative possibility may be the indirect effect of helper/inducer T-cells on a minor population of cyto- We were unable to demonstrate differences in numbers of proliferating cells or other immune cell types (macrophages, Leu-7-positive cells, and Tac-positive cells) among patients with and without spontaneous regression. However, small differences may not have been identified by the methods used in this study. In addition, we could only study a small number of patients with spontaneous regression, and other differences might emerge if it were possible to study additional cases in the future. Investigative studies of follicular lymphomas have been handicapped by the lack of suitable animal models and the inability to develop long-term cell lines from these lymphomas. If animal models or suitable cell culture methods are developed for follicular lymphomas, it may be possible to more directly assess the role of regulatory T-subsets in these clinically important lymphomas.
